Generation Bio Co. (GBIO) Financial Statements (2024 and earlier)

Company Profile

Business Address 301 BINNEY STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments279,091375,145262,327
Cash and cash equivalents93,171375,14562,889
Short-term investments185,920 199,438
Receivables395  
Prepaid expense 1,180  
Other current assets 259  
Other undisclosed current assets6,0914,0415,408
Total current assets:287,016379,186267,735
Noncurrent Assets
Operating lease, right-of-use asset59,20865,143 
Property, plant and equipment22,21525,88623,781
Restricted cash and investments5,6925,6922,051
Deferred costs434461336
Other noncurrent assets1,699403252
Total noncurrent assets:89,24897,58526,420
TOTAL ASSETS:376,264476,771294,155
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,67910,5647,357
Employee-related liabilities7,9707,5796,150
Accounts payable6622,023267
Accrued liabilities1,047962940
Deferred revenue   
Deferred rent credit   1,389
Other liabilities426676702
Other undisclosed current liabilities9,0457,5681,772
Total current liabilities:19,15018,80811,220
Noncurrent Liabilities
Long-term debt and lease obligation:  76,217 
Liabilities, other than long-term debt74,621 14,922
Deferred revenue   
Deferred rent credit   14,922
Operating lease, liability74,62176,217 
Other undisclosed noncurrent liabilities  (76,217) 
Total noncurrent liabilities:74,62176,21714,922
Total liabilities:93,77195,02526,142
Equity
Equity, attributable to parent282,493381,746268,013
Common stock665
Additional paid in capital727,335689,866456,974
Accumulated other comprehensive income (loss)(83) 9
Accumulated deficit(444,765)(308,126)(188,975)
Total equity:282,493381,746268,013
TOTAL LIABILITIES AND EQUITY:376,264476,771294,155

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Revenues
(Other undisclosed Revenues)
   
Gross profit:   
Operating expenses(141,182)(119,101)(81,114)
Operating loss:(141,182)(119,101)(81,114)
Nonoperating income (expense)4,543(50)591
Investment income, nonoperating2,289(766)(249)
Loss from continuing operations before income taxes:(136,639)(119,151)(80,523)
Income tax expense (38,956)(37,934)(27,855)
Other undisclosed loss from continuing operations   
Loss from continuing operations:(175,595)(157,085)(108,378)
Loss before gain (loss) on sale of properties:(157,085)(108,378)
Other undisclosed net income38,95637,93427,855
Net loss available to common stockholders, diluted:(136,639)(119,151)(80,523)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Net loss:(136,639)(119,151)(80,523)
Comprehensive loss:(136,639)(119,151)(80,523)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(83)(9)9
Comprehensive loss, net of tax, attributable to parent:(136,722)(119,160)(80,514)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: